New “Fast-Fail” Initiative Takes Aim at Psychosis
As pharma retreats from developing new drugs for mental disorders, a new Columbia/NYSPI initiative is stepping in.
- CUMC Home
- |
- Columbia University
- |
- A-Z Listing
- |
- Find People
- |
- Research Profiles
- |
- Map
- |
- RSS
- |
- Giving
